SCHEMBL30657929

SCHEMBL30657929

Cc1cnc2c(c1)OCCN2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.54
ALDH1A1 P00352 2/20 0.46
GAA P10253 2/20 0.46
HSD17B10 Q99714 2/20 0.46
MAPT P10636 1/20 0.46
ALOX5AP P20292 13/20 0.42
FEN1 P39748 13/20 0.42
ADRA2A P08913 1/20 0.35
ADRA2C P18825 1/20 0.35
ADRA1D P25100 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35
KDM4E B2RXH2 1/20 0.34
GLA P06280 1/20 0.34
HPGD P15428 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
ATM Q13315 1/20 0.34
RET P07949 1/20 0.34
IMPDH2 P12268 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL91447 1.00 GRM5 (0.54) GRM5ALDH1A1GAAHSD17B10MAPT
SCHEMBL21201805 0.90 GRM5 (0.44) GRM5ALDH1A1GAAHSD17B10MAPT
SCHEMBL17430662 0.81 GRM5 (0.36) GRM5ALDH1A1GAAHSD17B10MAPT
SCHEMBL12462535 0.79 GRM5 (0.54) GRM5ALDH1A1GAAHSD17B10MAPT
SCHEMBL13114366 0.79 GRM5 (0.54) GRM5ALDH1A1GAAHSD17B10MAPT
SCHEMBL18307148 0.79 GRM5 (0.54) GRM5ALDH1A1GAAHSD17B10MAPT
SCHEMBL858890 0.79 GRM5 (0.54) GRM5ALDH1A1GAAHSD17B10MAPT
SCHEMBL12019744 0.78 GRM5 (0.50) GRM5ALDH1A1GAAHSD17B10MAPT
SCHEMBL84582 0.78 GRM5 (0.50) GRM5ALDH1A1GAAHSD17B10MAPT
SCHEMBL12020144 0.78 GRM5 (0.60) GRM5ALDH1A1GAAHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119677738-A Compounds and uses thereof 福宏治疗公司 2025-03-21 CN disclosed
EP-4522280-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2025-03-19 EP disclosed
WO-2023220219-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2023-11-16 WO disclosed